HRSA did not approve J&J's newly proposed 340B rebate model, an agency spokesperson told 340B Report.
News Alert
HRSA Says Johnson & Johnson’s New 340B Rebate Model Did Not Receive Agency Approval, Is ‘Inconsistent’ with 340B Statute
Views
The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
